Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Evaluation Conformal Radiotherapy for Gynecologic Cancer

This study has been completed.
Information provided by:
Istanbul University Identifier:
First received: September 4, 2007
Last updated: NA
Last verified: August 2007
History: No changes posted

The purpose of this study is comparision conformal radiotherapy for gynecologic cancer

Condition Intervention
Radiation Therapy
Radiation: conformal radiotherapy

Study Type: Interventional
Study Design: Intervention Model: Parallel Assignment
Masking: Open Label

Further study details as provided by Istanbul University:

Study Start Date: August 2006

Genders Eligible for Study:   Female

Inclusion Criteria:

  • Gynecologic cancer

Exclusion Criteria:

  • Metastases
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its identifier: NCT00525538

Cerrahpasa Medical Faculty Department of Radiation Oncology
Istanbul, Fatih, Turkey, 34098
Sponsors and Collaborators
Istanbul University
Principal Investigator: filiz munzuroglu Cerrahpasa Medical Faculty Department of Radiation Oncology
  More Information

No publications provided Identifier: NCT00525538     History of Changes
Other Study ID Numbers: IUCMFRO-07
Study First Received: September 4, 2007
Last Updated: September 4, 2007
Health Authority: Turkey: Ethics Committee processed this record on March 02, 2015